Rx only · Tablet, Film Coated · Oral
Glipizide And Metformin Hcl
Glipizide + Metformin Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.242
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.6K
Rx · 2026 Q1
421K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 6 | SUPPLYING |
| Proficient Rx LP | unknown | 3 | SUPPLYING |
| Chartwell RX, LLC | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 25, 2015RECALLRecall (Class II): GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage…
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. — Recalling firm: Heritage Pharmaceuticals, Inc. — U.S. Nationwide including Puerto Rico.
Pill